CORRECTION article

Front. Endocrinol., 21 December 2022

Sec. Cardiovascular Endocrinology

Volume 13 - 2022 | https://doi.org/10.3389/fendo.2022.1114158

Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study

  • 1. Center for Clinical and Epidemiologic Research, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China

  • 2. The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing, China

  • 3. Beijing Municipal Key laboratory of Clinical Epidemiology, Beijing, China

  • 4. School of Information and Electronics, Beijing Institute of Technology, Beijing, China

In the published article, there was an error regarding the affiliations for Jiangtao Li, Dong Zhao, Qiuju Deng, Yongchen Hao, Miao Wang, Jiayi Sun, Jun Liu, Guandi Ren, Huiqi Li, Yue Qi and Jing Liu.

As well as having affiliation(s) 1,2, Jiangtao Li, Dong Zhao, Qiuju Deng, Yongchen Hao, Miao Wang, Jiayi Sun, Jun Liu, Yue Qi and Jing Liu should also have affiliation 3. Guandi Ren and Huiqi Li should not have affiliation 3.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

serum calcium, retinopathy, microvascular disease, non-diabetic, convolutional neural network

Citation

Li J, Zhao D, Deng Q, Hao Y, Wang M, Sun J, Liu J, Ren G, Li H, Qi Y and Liu J (2022) Corrigendum: Reduced serum calcium is associated with a higher risk of retinopathy in non-diabetic individuals: The Chinese Multi-provincial Cohort Study. Front. Endocrinol. 13:1114158. doi: 10.3389/fendo.2022.1114158

Received

02 December 2022

Accepted

05 December 2022

Published

21 December 2022

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Yue Qi, , ; Jing Liu,

This article was submitted to Cardiovascular Endocrinology, a section of the journal Frontiers in Endocrinology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics